These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36988207)

  • 21. Advances in kidney-targeted drug delivery systems.
    Chen Z; Peng H; Zhang C
    Int J Pharm; 2020 Sep; 587():119679. PubMed ID: 32717283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomimetic camouflage delivery strategies for cancer therapy.
    Asrorov AM; Gu Z; Li F; Liu L; Huang Y
    Nanoscale; 2021 May; 13(19):8693-8706. PubMed ID: 33949576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical nanoparticles for next generation drug delivery to the lungs.
    van Rijt SH; Bein T; Meiners S
    Eur Respir J; 2014 Sep; 44(3):765-74. PubMed ID: 24791828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction-responsive polymers for drug delivery in cancer therapy-Is there anything new to discover?
    Monteiro PF; Travanut A; Conte C; Alexander C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1678. PubMed ID: 33155421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanomedicine: the promise and challenges in cancer chemotherapy.
    Naguib YW; Cui Z
    Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
    [No Abstract]   [Full Text] [Related]  

  • 27. Magnetic iron oxide nanoparticles as drug carriers: clinical relevance.
    El-Boubbou K
    Nanomedicine (Lond); 2018 Apr; 13(8):953-971. PubMed ID: 29376469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current progress in nanotechnology applications for diagnosis and treatment of kidney diseases.
    Lee SH; Lee JB; Bae MS; Balikov DA; Hwang A; Boire TC; Kwon IK; Sung HJ; Yang JW
    Adv Healthc Mater; 2015 Sep; 4(13):2037-45. PubMed ID: 26121684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases.
    Paluszkiewicz P; Martuszewski A; Zaręba N; Wala K; Banasik M; Kepinska M
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesoporous silica nanoparticles for pulmonary drug delivery.
    García-Fernández A; Sancenón F; Martínez-Máñez R
    Adv Drug Deliv Rev; 2021 Oct; 177():113953. PubMed ID: 34474094
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Cevaal PM; Ali A; Czuba-Wojnilowicz E; Symons J; Lewin SR; Cortez-Jugo C; Caruso F
    ACS Nano; 2021 Mar; 15(3):3736-3753. PubMed ID: 33600163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticles in Combating Cancer: Opportunities and Limitations. A Brief Review.
    Pedziwiatr-Werbicka E; Horodecka K; Shcharbin D; Bryszewska M
    Curr Med Chem; 2021; 28(2):346-359. PubMed ID: 32000637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomedicine for Cystic Fibrosis.
    Ong V; Mei V; Cao L; Lee K; Chung EJ
    SLAS Technol; 2019 Apr; 24(2):169-180. PubMed ID: 30707858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Nano-War Against Complement Proteins.
    Wang Z; Brenner JS
    AAPS J; 2021 Sep; 23(5):105. PubMed ID: 34505951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
    Bharali DJ; Mousa SA
    Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No small matter: a perspective on nanotechnology-enabled solutions to fight COVID-19.
    Jones GW; Monopoli MP; Campagnolo L; Pietroiusti A; Tran L; Fadeel B
    Nanomedicine (Lond); 2020 Oct; 15(24):2411-2427. PubMed ID: 32873192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diverse Applications of Nanomedicine.
    Pelaz B; Alexiou C; Alvarez-Puebla RA; Alves F; Andrews AM; Ashraf S; Balogh LP; Ballerini L; Bestetti A; Brendel C; Bosi S; Carril M; Chan WC; Chen C; Chen X; Chen X; Cheng Z; Cui D; Du J; Dullin C; Escudero A; Feliu N; Gao M; George M; Gogotsi Y; Grünweller A; Gu Z; Halas NJ; Hampp N; Hartmann RK; Hersam MC; Hunziker P; Jian J; Jiang X; Jungebluth P; Kadhiresan P; Kataoka K; Khademhosseini A; Kopeček J; Kotov NA; Krug HF; Lee DS; Lehr CM; Leong KW; Liang XJ; Ling Lim M; Liz-Marzán LM; Ma X; Macchiarini P; Meng H; Möhwald H; Mulvaney P; Nel AE; Nie S; Nordlander P; Okano T; Oliveira J; Park TH; Penner RM; Prato M; Puntes V; Rotello VM; Samarakoon A; Schaak RE; Shen Y; Sjöqvist S; Skirtach AG; Soliman MG; Stevens MM; Sung HW; Tang BZ; Tietze R; Udugama BN; VanEpps JS; Weil T; Weiss PS; Willner I; Wu Y; Yang L; Yue Z; Zhang Q; Zhang Q; Zhang XE; Zhao Y; Zhou X; Parak WJ
    ACS Nano; 2017 Mar; 11(3):2313-2381. PubMed ID: 28290206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein Nanoparticles: Uniting the Power of Proteins with Engineering Design Approaches.
    Habibi N; Mauser A; Ko Y; Lahann J
    Adv Sci (Weinh); 2022 Mar; 9(8):e2104012. PubMed ID: 35077010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging Trends in Nanomedicine for Improving Ocular Drug Delivery: Light-Responsive Nanoparticles, Mesoporous Silica Nanoparticles, and Contact Lenses.
    Rodrigues FSC; Campos A; Martins J; Ambrósio AF; Campos EJ
    ACS Biomater Sci Eng; 2020 Dec; 6(12):6587-6597. PubMed ID: 33320633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.